ERYTECH Provides Business Update and Reports Financial Results for Full Year 2016 Post author:admERY Post published:March 2, 2017 Post category:Newsroom ERYTECH today provided a business update and reported its financial results for the year ended December 31, 2016. You Might Also Like ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016 Erytech to Hold Full-year 2015 Business Update Conference Call on February 24, 2016 February 18, 2016 ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 July 17, 2018
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
Erytech to Hold Full-year 2015 Business Update Conference Call on February 24, 2016 February 18, 2016
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 July 17, 2018
